[Congressional Record Volume 150, Number 66 (Wednesday, May 12, 2004)]
[Extensions of Remarks]
[Pages E817-E818]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




                IN RECOGNITION OF DR. PHILIP C. HOPEWELL

                                 ______
                                 

                           HON. NANCY PELOSI

                             of california

                    in the house of representatives

                         Tuesday, May 11, 2004

  Ms. PELOSI. Mr. Speaker, I rise to congratulate my constituent, 
Philip C. Hopewell, MD. The American Lung Association has awarded Dr. 
Hopewell, a leader in the fight against tuberculosis, the Edward 
Livingston Trudeau Medal to recognize his lifelong contribution to the 
prevention diagnosis and treatment of lung disease.
  In 1970, Dr. Hopewell took a brief sabbatical from his internal 
medicine residency program at the University of California San 
Francisco to work in war-torn Nigeria as a consultant to the Nigerian 
government on their tuberculosis control program. Dr. Hopewell's 
experience gave him first hand knowledge of the problems faced by 
developing countries in implementing effective tuberculosis control 
programs. More importantly, it gave Dr. Hopewell the belief that 
effective TB control programs can be established in the developing 
world.
  Since 1971, Dr. Hopewell has shared his expertise in designing and 
implementing TB control programs. Most recently, Dr. Hopewell has 
worked as vice-chair of the Strategic and Technical Advisory Group for 
the World Health Organization (WHO) Stop TB Department. In his capacity 
at the WHO-STOP TB Partnership, Dr. Hopewell has provided technical 
expertise to developing nations around the globe on development and 
implementation of effective TB programs.
  I first became aware of Dr. Hopewell's work about five years ago when 
we met to discuss increasing the U.S. committee to TB control at the 
U.S. Agency for International Development (USAID). At that time, the 
USAID contribution to international TB control was essentially zero. 
Dr. Hopewell made it clear to all who would listen that TB control 
programs can work in the developing world and it is in our country's 
best interests to take an active role. Through Dr. Hopewell's work and 
the hard work of many others, the U.S. support for international TB 
control has grown. Yet there is more to be done, as Dr. Hopewell always 
reminds me.

[[Page E818]]

  While the world has benefited from Dr. Hopewell's work, he has not 
ignored the problem of TB at home in San Francisco. Dr. Hopewell became 
involved in the San Francisco tuberculosis control program through his 
supervision of a contract by which clinical services were provided to 
the Department of Public Health. The affiliation of an academic 
institution and an effective public health tuberculosis control program 
has provided and continues to provide important opportunities for 
training and research in many aspects of tuberculosis control. This 
combination forms the foundation of the Frances J. Curry National 
Tuberculosis Center, directed by Dr. Hopewell. The Curry Center is one 
of three CDC-funded model centers in the country.
  Mr. Speaker, Dr. Hopewell is a teacher, a healer, a scientist and an 
international humanitarian. I join many throughout this country in 
recognizing and honoring Dr. Hopewell and his lifetime of achievement 
in the research, prevention and treatment of lung disease.

                          ____________________